Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Karmanos Offering Cross-Training for Cancer Survivors

WOMC Karmanos Cancer Institute and Wayne State University offer another Cross Training and Physical Activity: A Better Life Experience (CAPABLE) s...

Read More

Department of Defense Grant Assists Karmanos Researchers Studying New Treatments for Ovarian Cancer

Gen Sheng Wu, Ph.D., member of the Molecular Therapeutics Research Program at the Barbara Ann Karmanos Cancer Institute and professor of Oncology ...

Read More

The Forgotten Cancer: What to Know About Sarcoma

Sarcoma is a type of cancer that develops in tissues or bones. There are more than 70 subtypes of sarcoma cancers, with bone and soft tissue sarco...

Read More
News

WOMC | Karmanos Offering Cross-Training for Cancer Survivors

Listen Now

WWJ | Eye on Health: LGBTQ+ and Cancer Treatment

Listen Now

97.1 The Ticket | Pink Out the Park

Listen Now